Global Conference on Vaccines Research and Development
2021-08-26 - 2021-08-28 | Paris, France
The conference aims to empower future generations in different fields of Vaccinology to explore exciting research outcomes that lie in tune with the objectives and theme of this exciting event. It further helps you enhance your understanding of commercial, scientific and regulatory issues that affect strategic decision making in the Vaccine Sector.
This global conference sets the stage for brain-storming discussions among the participants with its enriching Q&A sessions, round table discussions and technical workshops and provides know-how of the latest methodologies and technicalities of Vaccines. Inspiring and educating talks from eminent scientists together with keynote lectures, plenary sessions, and video and poster presentations that span across the length and breadth of this conference.
We look forward to seeing you at Vaccines Conference-2021 in Paris, France.
Click here to learn more.
Click here to view the agenda.
Click here to register.

Public Workshop: Science and Regulation of Bacteriophage Therapy
2021-08-30 - 2021-09-01 | VIRTUAL EVENT
The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled “Science and Regulation of Bacteriophage Therapy.” The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with bacteriophage therapy.
Click here to learn more.
Click here to view the agenda.
Click here to register.

American Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting
2021-08-31 - 2021-09-03 | San Diego, California
Click here to learn more.
Click here to register.

BLUE KNIGHT™ Webinar: Antimicrobial Resistance – Breakthrough Innovation and Breaking Barriers
2021-09-15 10:00 - 11:00 (America/New_York) | VIRTUAL EVENT
As multi-drug resistant bacteria become increasingly threatening to global public health and existing antibiotics are becoming ineffective, the global community of public and private organizations and life science innovators are rallying around the Antimicrobial Resistance challenge.
Johnson & Johnson Innovation has invited leading experts in the field to share their views. Why aren’t (enough) new antibiotics being developed to address the AMR challenge? What other innovations might help without increasing antibiotic resistance?
Join the discussion as thought leaders share their views on the challenges surrounding this global health threat and the potential solutions.
Topics will include:

Priority MDR bacterial pathogens of interest
Potential interventions to prevent and treat MDR bacterial infections
Barriers in the development and commercialization pathway
The need for policy change to address these barriers
The potential roles of various organizations and public-private partnerships

*This program is part of BLUE KNIGHT™, a collaboration between Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA).
Click here to learn more.
Click here to view the agenda.
Click here to register.

2021 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
2021-09-21 - 2021-09-24 | Boston, Venue Forthcoming, Boston, MA, United States
The ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, scheduled to take place on Sept. 1-4, 2020 in Dublin, Ireland, has been cancelled due to the COVID-19 pandemic. Visit the ESCMID website for more details. The 2021 conference will take place on Sept. 21-24 in Boston, Mass.
Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development for AMR.
Additional details forthcoming.
Click here to learn more, additional details forthcoming.

18th International Conference on Pseudomonas
2021-09-27 - 2021-10-02 | Atlanta, Georgia
The scientific sessions include Genomics and gene regulation; Antimicrobial tolerance; Host-Pathogen interactions; Metabolism and Physiology; Harnessing the Potential of Pseudomonas species; Evolution and Coevolution; Ecology; and Multi-species Interactions.
Plenary Speaker: Fiona Brinkman, Canada, Fellow of the Royal Society of Canada
Keynote Speakers: Joseph Bondy-Denomy, Paul Turner, Barbara Kazmierczak, Gregg Beckham, Wei Huang, Jenna Gallie, Britt Koskella, and Jessica Scoffield
Click here to learn more.
Click here to view the agenda.
Click here to register.

The Vaccines Against Shigella and ETEC (VASE) Conference
2021-09-28 - 2021-09-30 | VIRTUAL EVENT
This is an international gathering dedicated to developing Shigella and enterotoxigenic Escherichia coli (ETEC) vaccines, hosted by PATH, a global nonprofit dedicated to achieving health equity.
Registration is now open for the VASE Virtual Symposium, which will be held online on 28 and 30 September 2021. Check out the full agenda and read the presentation abstracts. This fully virtual event will provide key updates on vaccines being developed for Shigella, (ETEC) and other emerging diarrheal pathogens, such as non-typhoidal Salmonella.
Click here to learn more.

North American Cystic Fibrosis Conference (NACFC) 2021
2021-09-30 - 2021-10-02 | San Antonio, Texas
The North American Cystic Fibrosis Conference (NACFC) is organized by the Cystic Fibrosis Foundation (CFF). The CFF 2021 onsite medical conference will be held from September 30 – October 2, 2021, in San Antonio Texas. Additional details forthcoming.
Click here to learn more.

Vaccinology in Africa Course 4-15 October 2021 (Online)
2021-10-04 - 2021-10-15 | VIRTUAL EVENT
The course provides state-of-the-art teaching in both human and veterinary vaccinology, drawing on the experience of the Jenner Institute at the University of Oxford, The Pirbright Institute, and this year’s African host, the KEMRI Wellcome Trust Research Programme in Kenya. These courses alternate between East and West Africa. In 2021, participation is limited to attendants currently working or studying in East Africa. Applications close 31 August 2021.
Click here to learn more.

Partnership to Fight Infectious Disease - Preparing for the Next Pandemic: An International Discussion
2021-10-06 08:00 - 09:00 (America/New_York) | Webinar
The Partnership to Fight Infectious Disease is convening a discussion among international experts to help inform domestic and international pandemic preparedness strategies building on lessons learned from the COVID-19 pandemic and other experiences.
CARB-X participants include Kevin Outterson, Executive Director, who will moderate the discussion.
Click here to learn more.
Click here to register.

ICARe Interdisciplinary Course on Antibiotics and Resistance
2021-10-16 - 2021-10-24 | Les Pensieres, Annecy, France
The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with trained scientists at the dawn of their careers. Cutting-edge approaches for the study of resistance and antibiotic discovery will be examined.
The objective of ICARe is to train the next generation of scientists implicated in the study of bacterial resistance to antibiotics and the finding of new drugs. ICARe is designed for assistant professors, new industry scientists, ID fellows, and postdoctoral research associates, as well as members from developing areas contending with the challenge of managing antibiotic resistance with limited resources. Attendance will be limited to 40 students and will reflect the global nature of the problem.
Click here to learn more.
Click here to view an overview of the programme.

ID Week 2021
2021-10-22 - 2021-10-25 | San Diego, Venue Forthcoming, CA, United States
Click here to learn more, additional details forthcoming.

CARB-X WEBINAR: European Celebration of 5 Years of Progress with CARB-X
2021-10-22 09:30 - 10:30 (America/New_York) | WEBINAR, Webinar, Webinar, United States
European Celebration of 5 Years of Progress with CARB-X
A virtual discussion of progress and plans to accelerate innovation globally
22nd of October, 2021, 3:30 – 4:30pm CET / 9:30 – 10:30am ET
Antibiotic-resistance undermines the safety net for modern medicine. Chemotherapy, surgeries, transplantation, childbirth – all of these and more depend on antibiotics to treat infection. At least 700,000 people die each year due to antibiotic-resistant (AMR) infections, according to a recent WHO report. A recent Lancet publication from the European Center for Disease Prevention and Control (ECDC) estimates that approximately 33,000 deaths in the EU each year can be attributed to AMR, and an Organization of Economic Cooperation & Development OECD report calculates about 1.1 billion Euros are required for the health care systems of EU/EEA countries to address AMR.
CARB-X and its partners are taking action. CARB-X has funded 92 projects in 12 countries totaling more than $360 million since it launched in 2016. In Europe, the support of Wellcome Trust, the German Ministry of Health and Education, and the UK Global AMR Innovation Fund was critical to this progress over the past five years.
Today, the CARB-X portfolio is the world’s largest and most scientifically diverse antibacterial R&D portfolio. We are currently accelerating projects focused on the most serious antibiotic-resistant bacteria, including new classes of antibiotics and non-traditional agents, vaccines and other preventatives such as CRISPR-phage, microbiome-modifying agents and antibodies, and rapid diagnostics.
Please join us for a virtual discussion of the critical role that CARB-X and its global partners play in driving the development of innovative products to address the antibiotic-resistant bacteria health crisis.
CARB-X Executive Director Kevin Outterson will highlight achievements, especially in Europe and speak to CARB-X’s future vision and strategy.
European-based funders of CARB-X will outline their objectives and strategy in preparedness and how CARB-X delivery over 2016-2021 has met some of these goals.
Several European product developers in the current CARB-X portfolio will speak about their innovative products and their experience working with CARB-X.
A panel of experts will discuss antibiotics as the safety net for modern medicine and the challenges of bringing innovative products to patients in Europe.

Veronika von Messling – Director-General for Life Sciences at the German Federal Ministry of Education and Research (confirmed)
Florence Séjourné – Chief Executive Director of Da Volterra and President of BEAM Alliance (confirmed)
Sir Jeremy Farrar – Director of Wellcome Trust & Member of the One Health Global Leaders Group on AMR (confirmed)
Otto Cars – Founding Director of ReAct, Senior Professor, Infectious Diseases, Uppsala University, and former member of UN Inter-Agency Coordination Group on AMR (confirmed)

Click here to register, and to find out more about this important virtual meeting.

World Health Summit
2021-10-24 - 2021-10-26 | Berlin, Germany
The World Health Summit promotes a science-driven and broad approach to global health development with the Sustainable Development Goals (SDGs) at its core. Our key issues are therefore interdisciplinary, science-based, cross-sectoral, and concerted. They are vital to set the global health agenda for the years to come. Because health is more than medicine and health is a human right. Key issues include:

Access to Essential Medicine
Big Data
Biomedical Research
Climate Change and Health
Digital Innovation
Drugs and Vaccines
Evolutionary Medicine
Global Action Plan for Healthy Lives and Well-being for All
Global Health Security
Health in All Policies
Health Systems Strengthening
Pandemic Preparedness
Patient Safety
Planetary Health
Sustainable Development Goals (SDGs)
Translational Science
Universal Health Coverage

Click here to learn more.

BARDA Industry Day
2021-11-03 - 2021-11-04
BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities, interact with BARDA and ASPR staff, and network with public and private sector colleagues working in the Health Security space.
Additional details forthcoming.

World Antimicrobial Resistance Congress 2021
2021-11-08 - 2021-11-09 | Washington DC
Antimicrobial resistance (AMR) is one of the biggest global health crises facing the world today. The number of deaths attributed to AMR is expected to surpass the number of deaths from cancer worldwide by 2050. Yet combatting resistance globally and developing a robust arsenal of antibiotics continues to fall behind the pace of resistance.
Since 2015, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet, brainstorm ideas and formulate initiatives that can effectively tackle this pressing issue.
Industry leaders, innovative technology and solution providers, public authorities, international organizations, infectious disease clinicians, pharmacists and microbiologists are some of the 1,000+ attendees from over 50 countries who will gather this November 2021 at the World Anti-Microbial Resistance Congress.
The conference will gather global leaders in infectious diseases to meet, brainstorm and discuss the challenges and opportunities on the following areas:

Advancing antibiotic R&D and non-traditional therapies development
Enhancing the commercial landscape and marketplace for antibiotics and diagnostics
Developing innovative diagnostics solutions
Facilitating interactions between funders and developers
Improving antimicrobial stewardship guidelines and practice through technology
Implementing sustainable environmental and manufacturing practices
Tackling infection control at hospitals efficiently and cost-effectively
Applying genomics to easily detect resistant pathogens and to accelerate antibiotic R&D
Leveraging surveillance platforms and solutions to monitor outbreaks and increasing numbers of resistant pathogens locally, regionally, nationally and globally.

If you work in these key areas of AMR, then you must attend the World Anti-Microbial Resistance Congress 2021!
Click here to learn more.
Click here to view the agenda.
Click here to register.

9th ASM Conference on Biofilms
2021-11-14 - 2021-11-18 | Charlotte, North Carolina
The 9th ASM Conference on Biofilms will be coming to Charlotte, N.C. on Nov. 14 –18, 2021. Additional Details Forthcoming.
Biofilms have a tremendous impact on industrial, clinical and natural environments. 2021 ASM Biofilms will provide an interdisciplinary platform to discuss the latest biofilm research. Check back later for more details about the meeting. We look forward to seeing you next year.
Click here to learn more.
Click here to view the agenda.

3rd SCI-RSC Symposium on Antimicrobial Drug Discovery
2021-11-15 - 2021-11-16 | SCI, 14/15 Belgrave Square, London, SW1X 8PS, United Kingdom
At a time when antimicrobial resistance is decreasing the efficacy of existing treatments, it has never been more important that we refresh the drug pipeline with new therapeutics acting on new targets or exhibiting novel modes of action.
Fortunately, renewed interest from both industry and academia has led to a resurgence in antimicrobial drug discovery and interest in developing innovative technologies and approaches for combating infection.
Coinciding with WHO’s World Antibiotics Awareness week, this two-day meeting will examine the latest advances in antimicrobial drug discovery from a medicinal chemist’s perspective, focusing on the particular challenges associated with developing antimicrobials whilst also showcasing emerging strategies for tackling infection.
Bringing together leading exponents in the field from industry and academia, the meeting will appeal to anyone with an interest in antimicrobial resistance and antimicrobial drug discovery. And with great opportunities for academic–industrial partnerships, researchers from both sectors will also benefit from the networking opportunities that the meeting will offer.
Click here to learn more.
Email conferences@soci.org to register your interest.
Conference Team
Tel: +44 (0)20 7598 1561
Email: conferences@soci.org

EFPIA - Pandemic Prevention: how Europe can lead the fight against AMR
2021-11-16 08:00 - 09:30 (America/New_York) | VIRTUAL EVENT
You’re invited to join this virtual event on Tuesday, 16 November, 2021 at 14:00 – 15:30 CET.
The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not.
The World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, and major surgery will become too dangerous to perform. In the Pharmaceutical Strategy for Europe, the European Commission declared that “new business models are required” if we are to meet this challenge and succeed, spotlighting 2022 as the year when change needs to happen.

Join us to discuss how we can drive investment in antimicrobials R&D and set out a roadmap to a sustainable innovation ecosystem that will safeguard society against the threat of AMR.

CARB-X participants include Kevin Outterson, Executive Director.
Click here to learn more and register.

McGill AMR Innovation Summit
2021-11-19 14:00 - 15:00 (America/New_York) | VIRTUAL EVENT
Antimicrobials in the era of AMR
During World Antimicrobial Awareness Week (Nov. 18-24 2021), the McGill AMR Centre and Innovation + Partnership office are hosting the inaugural McGill AMR Innovation Summit, a virtual event aimed at discussing antimicrobial R&D and building collaborations and partnerships between McGill scientists and non-academic stakeholders.
Program

14:00-14:30 Keynote speaker Erin Duffy, PhD (public event)
14:30-15:00 Panel discussion (public event)
15:00-16:00 Industry-Academic networking event (private event)

Keynote speaker Erin Duffy, PhD, Chief of R&D, CARB-X
CARB-X is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With up to US$480 million to invest in 2016-22, CARB-X portfolio is the world’s largest early development pipeline in AMR.
Panel discussion Challenges and opportunities for antimicrobial R&D in the era of AMR
With experts from industry and academia.
• David Claveau, PhD, Director, Medical Affairs at AVIR Pharma
• Erin Duffy, PhD, Chief of Research & Development, CARB-X
• Joseph Mancini, PhD, Head of Pharmacology and Biologics, Senior Director at adMare BioInnovations
• Nicolas Moitessier, PhD, Professor in Chemistry (McGill), co-founder of Molecular Forecaster
• Martin Schmeing, PhD, Professor in Biochemistry (McGill), Director of Centre for Structural Biology
• Christopher Tan, PhD, Director, Business Development & Licensing, Search & Evaluation, Infectious Diseases & Vaccines at Merck Research Laboratories
Registration is free but required.
If you have any questions, please contact us at amrcentre@mcgill.ca
Click here to learn more.
Click here to register.

AMR Industry Alliance Panel on Supporting the Optimal Use of Antimicrobial Medicines through Innovation
2021-11-23 07:00 - 08:00 (America/New_York) | VIRTUAL EVENT
This year’s WAAW will take place 18-24 November 2021, with the theme “Spread Awareness, Stop Resistance”. You can read more about WHO’s WAAW campaign here.
The AMR Industry Alliance virtual panel session will be organized as short dialogues among experts from the public, private, academic and civil society sectors who will discuss key topics related to the optimal use of antimicrobial medicines as a means of controlling the spread of antimicrobial resistance (AMR).
The three short dialogues will focus on the following topics:

The role of diagnostics in guiding optimal use of antibiotics
Relevance of AMR stewardship in achieving the UN SDGs
Stop resistance! Collaborative approaches to tackling AMR

Speakers include:

Hanan H. Balkhy, Assistant-Director-General, AMR, WHO
Thomas Cueni, Chair, AMR Industry Alliance & Director-General, IFPMA
Otridah Kapona, National AMR Focal Point and Coordinator, Zambia National Public Health Institute, WHO STAG-AMR
Cecilia Ferreyra, Head of AMR Programme, FIND
Mukesh Kapila, Global Health and Humanitarian Affairs, University of Manchester, WHO STAG-AMR
Liz Tayler, Team Leader, Monitoring and National Action Plans AMR, WHO
Scott Weese, Professor, Ontario Veterinary College and Director, Centre for Public Health and Zoonoses, University of Guelph
Kevin Outterson, Executive Director, CARB-X
Pilar Ramon Pardo, AMR Advisor, PAHO
Peter Beyer, Senior Advisor and Team Lead, AMR, WHO
Jean-Louis Tissier, Vice-President, Public and Government Affairs, BioMérieux
Adam Zerda, Director, AMR Strategy and Program Development
Greg Frank, Director, Global Public Policy, Merck

Click here to learn more.
Click here to register.

ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
2021-12-08 - 2021-12-09 | VIRTUAL EVENT
The 2021 ASM/ESCMID Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance will take place online, Dec. 8-9, 2021.

Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance.

Click here to learn more.
Click here to view the agenda.
Click here to register.

Infection 2021: British Society for Antimicrobial Chemotherapy (BSAC) Winter Conference
2021-12-09 - 2021-12-10 | VIRTUAL EVENT
Join us as we celebrate 50 years of BSAC! Infection 2021 is an exciting two-day hybrid conference looking at the challenges and future of infection management and how we can rise the meet the challenge of antimicrobial resistance.
We encourage you to register for either in-person or virtual attendance and submit your abstracts for consideration for oral and poster presentation. All accepted abstracts will be published in JAC-Antimicrobial Resistance.
CARB-X participants include Kevin Outterson, Executive Director, who will be leading the session “The potential of de-linkage in addressing antimicrobial resistance” on Friday December 10th.
Click here to learn more.
Click here to view the agenda.

ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance - Bangkok, Thailand
2021-12-16 - 2021-12-17 | Bangkok, Thailand
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.
ICAAR 2021: 15. International Conference on Antibiotics and Antibiotic Resistance aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Antibiotics and Antibiotic Resistance. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Antibiotics and Antibiotic Resistance
Click here to learn more.
Click here to view the agenda.
Click here to register.

Stewardship can accelerate efforts to combat AMR
2022-02-03 18:00 - 19:00 (Asia/Kolkata) | VIRTUAL EVENT
CARB-X Compliance Manager, Rose Garson, will join Taslimarif Saiyed, PhD of Centre for Cellular and Molecular Platforms (C-CAMP) to speak on the role that stewardship and access play in combating #AMR.
✏️ Register: https://bit.ly/3o3op9B

Global Research on Antimicrobial Resistance (GRAM) Virtual Event
2022-02-04 17:00 - 18:30 (Europe/London) | VIRTUAL EVENT
The GRAM report was published in The Lancet on 20 January 2022. The online launch event will explore these compelling new findings on the global burden of AMR and regional patterns and trends for over 88 pathogen-drug combinations; celebrate the global collaboration and 100’s of data partnerships that made this study possible; consider how data can be harnessed to support governments, health systems and civil society to act and reduce the human-cost of AMR; and identify immediate actions that can help countries around the world protect their health systems against the threat of AMR.
Confirmed speakers include:

Professor Chris Murray, Director of the Institute for Health Metrics and Evaluation
Dame Sally Davies, UK Special Envoy on AMR
Dr Hanan Balkhy, Assistant Director General for Antimicrobial Resistance, World Health Organization
Dr Richard Horton, Editor-in-Chief of The Lancet

If you can join live register here. Places are limited so please register early to avoid disappointment.
If you cannot join live, but would like to receive the recording, please request the post-event recording here and a link to the recording will be sent once available. Please note a recording will also be shared with those joining live.
The GRAM project is a collaboration led by Institute for Health Metrics and Evaluation and the University of Oxford and was funded by the Fleming Fund, the Bill & Melinda Gates Foundation and Wellcome Trust.
If you have any queries, please email GlobalEvents@wellcome.org

Gordon Research Seminar: Biology of Acute Respiratory Infection (GRS)
2022-02-26 - 2022-02-27 | Four Points Sheraton / Holiday Inn Express, 1050 Schooner Drive, Ventura, CA, United States
Host-pathogen interactions during pulmonary health and disease
The Gordon Research Seminar on Biology of Acute Respiratory Infection is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting-edge ideas.
Chairs: Anukul T. Shenoy and Kristin M. Noell

Gordon Research Conference: Biology of Acute Respiratory Infection
2022-02-27 - 2022-03-04 | Four Points Sheraton / Holiday Inn Express, 1050 Schooner Drive, Ventura, CA, United States
Basic Mechanisms and Translational Science Contributing to the Global Impact of Pneumonia
The 2022 Gordon Research Conference on the Biology of Acute Respiratory Infections will center on biological events dictating pneumonia outcome and the degree to which these events have been or could be leveraged by clinical practice. This will benefit from integrated contributions across multiple disciplines, including but not limited to immunologists, microbiologists, and clinicians, resulting in a venue that uniquely assembles the world’s foremost experts in pneumonia research. In this way, the 2022 GRC on the Biology of Acute Respiratory Infection and the associated Gordon Research Seminar will cultivate an opportunity for creative and multidisciplinary discussions for this rapidly evolving area of investigation, maximizing the potential for innovative discoveries and clinical interventions.
Chairs: Lee J. Quinton and Stephania Cormier
Vice Chairs: Bethany B. Moore and Charles Dela Cruz

The Longitude Prize: AMR& Diagnostic Frontiers: Developing and increasing access to innovative diagnostics in and for low-and-middle-income countries (LMICs)
2022-03-03 14:00 - 16:00 (Europe/London) | VIRTUAL EVENT
Are you developing AMR diagnostics in or for an LMIC? Or do you have a product that could be adapted and tested for use in low resource settings?
Pitch your technology and get customer-driven feedback from a panel of global health representatives at the virtual event with FIND, the global alliance for diagnostics and CARB-X.
Register to pitch your product. Visit the Longitude Prize website for more information and to sign-up to the event.

Gordon Research Seminar: New Antibacterial Discovery and Development
2022-03-05 - 2022-03-06 | Renaissance Tuscany Il Ciocco, Via Giovanni Pascoli, Lucca (Barga), 55051, Italy
The chair is currently developing a description for this conference. This information will be available by May 5, 2021. Please check back for updates.
Click here to learn more.
Click here to register.
